Nurix Therapeutics Dividend
Dividend criteria checks 0/6
Nurix Therapeutics hat in der Vergangenheit keine Dividende gezahlt.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 2.7% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -US$2.93 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Improved Revenues Required Before Nurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Find Their Feet
Feb 20Nurix Therapeutics: Recovering Thanks To ASH, But I Think It's Priced Just Right For Now
Jan 16Here's Why We're Watching Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Situation
Dec 29Nurix Therapeutics, Inc.'s (NASDAQ:NRIX) 29% Dip In Price Shows Sentiment Is Matching Revenues
Oct 14Broker Revenue Forecasts For Nurix Therapeutics, Inc. (NASDAQ:NRIX) Are Surging Higher
Oct 13Here's Why We're Watching Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Situation
Sep 30Party Time: Brokers Just Made Major Increases To Their Nurix Therapeutics, Inc. (NASDAQ:NRIX) Earnings Forecasts
Apr 18We Think Nurix Therapeutics (NASDAQ:NRIX) Needs To Drive Business Growth Carefully
Apr 15We're Keeping An Eye On Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Rate
Nov 28Nurix Therapeutics GAAP EPS of -$0.90 beats by $0.07, revenue of $10.79M misses by $1.29M
Oct 06Nurix Therapeutics GAAP EPS of -$1.01 misses by $0.02, revenue of $11.43M beats by $0.93M
Jul 07FDA approves expansion of Nurix Therapeutics' phase 1 trial of NX-1607 into the U.S.
Jun 30We Think Nurix Therapeutics (NASDAQ:NRIX) Needs To Drive Business Growth Carefully
Jun 21We Think Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Drive Business Growth
Mar 07Nurix: Advancing Targeted Protein Modulation Therapies
Nov 21Companies Like Nurix Therapeutics (NASDAQ:NRIX) Can Afford To Invest In Growth
Nov 21We're Not Worried About Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn
Jul 24Nurix Therapeutics appoints new operations chief
Jun 21Nurix Therapeutics adds Clay Siegall to its board of directors
Jun 01Here's Why We're Not At All Concerned With Nurix Therapeutics' (NASDAQ:NRIX) Cash Burn Situation
Apr 15Industry Analysts Just Upgraded Their Nurix Therapeutics, Inc. (NASDAQ:NRIX) Revenue Forecasts By 10%
Feb 21Nurix Therapeutics, Inc. (NASDAQ:NRIX) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 18Rainbows and Unicorns: Nurix Therapeutics, Inc. (NASDAQ:NRIX) Analysts Just Became A Lot More Optimistic
Jan 31Stability and Growth of Payments
Fetching dividends data
Stabile Dividende: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Dividende je Aktie von NRIX in der Vergangenheit stabil geblieben ist.
Wachsende Dividende: Unzureichende Daten, um festzustellen, ob die Dividendenzahlungen von NRIX gestiegen sind.
Dividend Yield vs Market
Nurix Therapeutics Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (NRIX) | n/a |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.7% |
Industry Average (Biotechs) | 2.7% |
Analyst forecast in 3 Years (NRIX) | n/a |
Bemerkenswerte Dividende: Es ist nicht möglich, die Dividendenrendite von NRIX im Vergleich zu den unteren 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Hohe Dividende: Es ist nicht möglich, die Dividendenrendite von NRIX im Vergleich zu den besten 25 % der Dividendenzahler zu bewerten, da das Unternehmen keine aktuellen Ausschüttungen gemeldet hat.
Earnings Payout to Shareholders
Abdeckung der Erträge: Unzureichende Daten zur Berechnung der Ausschüttungsquote von NRIX, um festzustellen, ob die Dividendenzahlungen durch die Gewinne gedeckt sind.
Cash Payout to Shareholders
Cashflow-Deckung: Es ist nicht möglich, die Nachhaltigkeit der Dividende zu berechnen, da NRIX keine Ausschüttungen gemeldet hat.